国际医药卫生导报2010，Vol.16Issue(12)：1467-1469,3.DOI:10.3760/cma.j.issn.1007-1245.2010.12.023
低分子肝素钙联合参脉注射液治疗慢性肺源性心脏病的疗效观察
Low molecular weight heparins calcium combined with Shengmai injection for chronic cor pulmonale
摘要
Abstract
Objective To explore the efficacy of low molecular weight heparins calcium combined with Shengmai injection in the treatment of chronic cor pulmonale. Methods 50 patients with chronic cor pulmonale were randomly assigned to receive conventional therapy including administration of continuous low-flow oxygen, antibiotics, expectorants, bronchodilators, digitalis glycosides, and diuretics (control group, 25 patients), or the same conventional therapy plus low molecular weight heparins calcium and Shangmai injection (study group, 25 patients). Results There was signigicant difference in the total effective rate between the study group and the control group in the (100% vs. 80%, P<0.05). ConclusionsLow molecular weight heparins calcium combined with Shengmai injection is effective in improving clinical symptoms, and increasing PaCO2 while reducing PaCO2, thus is an effective therapy for chronic pulmonary heart disease.关键词
低分子肝素钙/参脉注射液/慢性肺源性心脏病Key words
Low molecular weight heparins calcium/ Shenmai injection/ Chronic pulmonary heart disease引用本文复制引用
黄英虎,孔祥伟..低分子肝素钙联合参脉注射液治疗慢性肺源性心脏病的疗效观察[J].国际医药卫生导报,2010,16(12):1467-1469,3.
